BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$462M |
| 2 |
UnitedHealth
UNH
|
+$441M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$429M |
| 4 |
Analog Devices
ADI
|
+$347M |
| 5 |
Apple
AAPL
|
+$342M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$536M |
| 3 |
Netflix
NFLX
|
+$316M |
| 4 |
PepsiCo
PEP
|
+$293M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$206M |
Sector Composition
| 1 | Technology | 25.21% |
| 2 | Financials | 10.94% |
| 3 | Healthcare | 10.54% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Assembly Biosciences
ASMB
$168M
| $2.89K | ﹤0.01% |
302
| – | – |
|
3927
Mitsubishi UFJ Financial
MUFG
$177B
| $2.86K | ﹤0.01% |
210
| – | – |
|
3928
HilleVax
HLVX
$105M
| $2.84K | ﹤0.01% |
1,961
-2,402
| -55% | -$3.48K |
|
3929
United Homes Group
UHG
$249M
| $2.84K | ﹤0.01% |
1,015
-291
| -22% | -$815 |
|
3930
Purple Innovation
PRPL
$114M
| $2.76K | ﹤0.01% |
3,639
-5,773
| -61% | -$4.38K |
|
3931
KORU Medical Systems
KRMD
$181M
| $2.72K | ﹤0.01% |
1,070
-58
| -5% | -$147 |
|
3932
Acrivon Therapeutics
ACRV
$47.8M
| $2.71K | ﹤0.01% |
1,336
-605
| -31% | -$1.23K |
|
3933
PepGen
PEPG
$48.5M
| $2.68K | ﹤0.01% |
1,907
-477
| -20% | -$670 |
|
|
CMPS
3934
Compass Pathways
CMPS
$499M
| $2.67K | ﹤0.01% |
933
+251
| +37% | +$718 |
|
|
ADAG
3935
Adagene
ADAG
$106M
| $2.62K | ﹤0.01% |
1,700
-3,000
| -64% | -$4.62K |
|
3936
Alto Neuroscience
ANRO
$105M
| $2.6K | ﹤0.01% |
1,205
-41,315
| -97% | -$89.2K |
|
3937
CervoMed
CRVO
$77M
| $2.6K | ﹤0.01% |
284
-13,489
| -98% | -$123K |
|
3938
Red Cat Holdings
RCAT
$1.1B
| $2.59K | ﹤0.01% |
+441
| New | +$2.59K |
|
3939
Shattuck Labs
STTK
$92M
| $2.58K | ﹤0.01% |
2,715
-5,224
| -66% | -$4.96K |
|
3940
Global X S&P 500 Covered Call ETF
XYLD
$3.12B
| $2.57K | ﹤0.01% |
65
-26,357
| -100% | -$1.04M |
|
3941
Alto Ingredients
ALTO
$91.3M
| $2.57K | ﹤0.01% |
2,250
-110
| -5% | -$125 |
|
3942
iShares S&P GSCI Commodity-Indexed Trust
GSG
$996M
| $2.55K | ﹤0.01% |
112
+111
| +11,100% | +$2.53K |
|
3943
Veritone
VERI
$206M
| $2.54K | ﹤0.01% |
1,094
| – | – |
|
3944
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$151M
| $2.51K | ﹤0.01% |
92
-234
| -72% | -$6.38K |
|
3945
iShares Core S&P US Value ETF
IUSV
$22.1B
| $2.49K | ﹤0.01% |
+27
| New | +$2.49K |
|
3946
Socket Mobile
SCKT
$8.08M
| $2.49K | ﹤0.01% |
2,200
-801
| -27% | -$905 |
|
3947
Vista Gold
VGZ
$229M
| $2.48K | ﹤0.01% |
+3,000
| New | +$2.48K |
|
3948
Pharvaris
PHVS
$1.49B
| $2.48K | ﹤0.01% |
158
+58
| +58% | +$911 |
|
3949
iShares Preferred and Income Securities ETF
PFF
$14.7B
| $2.46K | ﹤0.01% |
80
| – | – |
|
3950
RAPT Therapeutics
RAPT
$268M
| $2.43K | ﹤0.01% |
249
-274
| -52% | -$2.67K |
|